Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

3D-printed biosensor with poly(dimethylsiloxane) reservoir for magnetic separation and quantum dots-based immunolabeling of metallothionein

Z. Heger, J. Zitka, N. Cernei, S. Krizkova, M. Sztalmachova, P. Kopel, M. Masarik, P. Hodek, O. Zitka, V. Adam, R. Kizek,

. 2015 ; 36 (11-12) : 1256-1264. [pub] 20150518

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010498

Grant support
NT14337 MZ0 CEP Register

Currently, metallothioneins (MTs) are extensively investigated as the molecular biomarkers and the significant positive association of the MT amount was observed in tumorous versus healthy tissue of various types of malignant tumors, including head and neck cancer. Thus, we proposed a biosensor with fluorescence detection, comprising paramagnetic nanoparticles (nanomaghemite core with gold nanoparticles containing shell) for the magnetic separation of MT, based on affinity of its sulfhydryl groups toward gold. Biosensor was crafted from PDMS combined with technology of 3D printing and contained reservoir with volume of 50 μL linked to input (sample/detection components and washing/immunobuffer) and output (waste). For the immunolabeling of immobilized MT anti-MT antibodies conjugated to CdTe quantum dots through synthetic heptapeptide were employed. After optimization of fundamental conditions of the immunolabeling (120 min, 20°C, and 1250 rpm) we performed it on a surface of paramagnetic nanoparticles in the biosensor reservoir, with evaluation of fluorescence of quantum dots (λexc 400 nm, and λem 555 nm). The developed biosensor was applied for quantification of MT in cell lines derived from spinocellular carcinoma (cell line 122P-N) and fibroblasts (122P-F) and levels of the biomarker were found to be about 90 nM in tumor cells and 37 nM in fibroblasts. The proposed system is able to work with low volumes (< 100 μL), with low acquisition costs and high portability.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010498
003      
CZ-PrNML
005      
20191113090903.0
007      
ta
008      
160408s2015 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/elps.201400559 $2 doi
024    7_
$a 10.1002/elps.201400559 $2 doi
035    __
$a (PubMed)25735231
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Heger, Zbyněk $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $7 xx0276759
245    10
$a 3D-printed biosensor with poly(dimethylsiloxane) reservoir for magnetic separation and quantum dots-based immunolabeling of metallothionein / $c Z. Heger, J. Zitka, N. Cernei, S. Krizkova, M. Sztalmachova, P. Kopel, M. Masarik, P. Hodek, O. Zitka, V. Adam, R. Kizek,
520    9_
$a Currently, metallothioneins (MTs) are extensively investigated as the molecular biomarkers and the significant positive association of the MT amount was observed in tumorous versus healthy tissue of various types of malignant tumors, including head and neck cancer. Thus, we proposed a biosensor with fluorescence detection, comprising paramagnetic nanoparticles (nanomaghemite core with gold nanoparticles containing shell) for the magnetic separation of MT, based on affinity of its sulfhydryl groups toward gold. Biosensor was crafted from PDMS combined with technology of 3D printing and contained reservoir with volume of 50 μL linked to input (sample/detection components and washing/immunobuffer) and output (waste). For the immunolabeling of immobilized MT anti-MT antibodies conjugated to CdTe quantum dots through synthetic heptapeptide were employed. After optimization of fundamental conditions of the immunolabeling (120 min, 20°C, and 1250 rpm) we performed it on a surface of paramagnetic nanoparticles in the biosensor reservoir, with evaluation of fluorescence of quantum dots (λexc 400 nm, and λem 555 nm). The developed biosensor was applied for quantification of MT in cell lines derived from spinocellular carcinoma (cell line 122P-N) and fibroblasts (122P-F) and levels of the biomarker were found to be about 90 nM in tumor cells and 37 nM in fibroblasts. The proposed system is able to work with low volumes (< 100 μL), with low acquisition costs and high portability.
650    _2
$a biosenzitivní techniky $7 D015374
650    _2
$a sloučeniny kadmia $x chemie $7 D019187
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a dimethylpolysiloxany $x chemie $7 D004129
650    _2
$a fluorescence $7 D005453
650    _2
$a zlato $x chemie $7 D006046
650    _2
$a lidé $7 D006801
650    _2
$a magnetismus $7 D008280
650    _2
$a kovové nanočástice $7 D053768
650    _2
$a metalothionein $x analýza $7 D008668
650    _2
$a nádory $x patologie $7 D009369
650    12
$a 3D tisk $7 D066330
650    _2
$a kvantové tečky $7 D045663
650    _2
$a telur $x chemie $7 D013691
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zítka, Jan $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. $7 _AN082271
700    1_
$a Cernei, Natalia $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $7 _AN063287
700    1_
$a Křížková, Soňa, $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $d 1981- $7 xx0105812
700    1_
$a Sztalmachová, Markéta $u Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0146032
700    1_
$a Kopel, Pavel, $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $d 1965- $7 mzk2005300913
700    1_
$a Masařík, Michal $u Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0104244
700    1_
$a Hodek, Petr, $u Department of Biochemistry, Faculty of Science, Charles University in Prague, Prague, Czech Republic. $d 1959- $7 jo2003186329
700    1_
$a Zítka, Ondřej, $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $d 1985- $7 xx0116134
700    1_
$a Adam, Vojtěch $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $7 xx0064599
700    1_
$a Kizek, René, $u Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic. Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic. $d 1972- $7 jn20001005291
773    0_
$w MED00001508 $t Electrophoresis $x 1522-2683 $g Roč. 36, č. 11-12 (2015), s. 1256-1264
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25735231 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20191113091140 $b ABA008
999    __
$a ok $b bmc $g 1113927 $s 934866
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 36 $c 11-12 $d 1256-1264 $e 20150518 $i 1522-2683 $m Electrophoresis $n Electrophoresis $x MED00001508
GRA    __
$a NT14337 $p MZ0
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Archiving options